Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Bafiertam vs. Vumerity in Healthy Volunteers
NCT05181215Phase 1Completed
- Sponsor
- Banner Life Sciences
- Start
- May 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of monomethyl fumarate in multiple sclerosis (MS) (2 arms), sponsored by Banner Life Sciences. Primary endpoints: Area Under the Concentration-Time Curve From Time Zero to Infinity at 24 hours and Maximum Plasma Concentration at 24 hours. Started May 2021; status: completed.
02
Drugs
monomethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT05181215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05181215.